| With IPO near Infinity signs rich pact with MedImmune | | Posted Wednesday, August 30, 2006 7:02:47 AM by Blog57 Team | | Just two weeks before it expects to go public, Infinity Pharmaceuticals Inc. of Cambridge yesterday said it had signed a multi million - dollar deal with Maryland biotechnology company MedImmune Inc. to co develop drugs that could potentially treat several kinds of cancer. MedImmune will pay Infinity $70 million to share the rights to any drugs that emerge from Infinity's two most advanced development programs. If its experimental drugs succeed and reach the market, total payments to Infinity could reach $500 million. Since its founding in 2001, Infinity has been a prolific deal maker, signing agreements with large drug companies Amgen Inc. , Johnson & Johnson , and Novartis AG . In most of those deals, Infinity retained full rights to the drugs it was developing, while offering the larger companies access to Infinity's library of potential drug molecules, which are based on a Harvard University technology for creating new chemicals.... | |
| |
| | | Roche files Xeloda for stomach cancer in Europe | | Posted Saturday, July 29, 2006 12:57:25 AM by Blog57 Team | | ZURICH, July 21 (Reuters) - Swiss drugmaker Roche (ROG.VX: Quote, Profile, Research) has filed its Xeloda drug in Europe for the treatment of advanced stomach cancer, the group said on Friday. The European Medicines Agency has accepted the filing for a new indication in Europe for Xeloda in combination with another chemotherapy, cisplatin, for treating patients with advanced stomach cancer, Roche said. Last month a late-stage study showed Xeloda combined with the treatment cisplatin was effective in patients with advanced stomach cancer. Xeloda is already used for breast and colon cancer. © Reuters 2006. All Rights Reserved. #upsell3 { margin-right: 0px; }.upsellThumbnail { margin-right: 10px; display:inline; } .upsellThumbnail p { margin: 0px 2px 0px 2px; padding: 0px; } .upsellImage { width: 138px; height: 65px; border: 1px solid #CCC; overflow: hidden; margin-bottom: 3px; text-align: center; background: #000; } .upsellImage img { border: none; margin: 0px; } .... | |
| |
| | | Mother-daughter team take breast cancer fight on road | | Posted Friday, June 30, 2006 10:58:04 AM by Blog57 Team | | An Eagle River mother and daughter are taking up the fight against breast cancer one step at a time. Helena Beck, owner of Studio La Tulipe, and her 16-year-old daughter, Cortney, are planning to take to the streets of Boston Aug. 4 through 6 as they participate in the Breast Cancer 3-Day Expo, which takes walkers on a 60-mile, three-day walking tour of the city while raising funds for breast cancer treatment and research. Helena said she has been a volunteer with cancer-oriented projects before, but was inspired to participate in the walk by her neighbor, Evelyn, a cancer survivor who has overcome breast, stomach, colon and adrenal gland cancer. She said she wanted to participate in the walk with Cortney as a show of support for her neighbor of three years. "It affects so many women around us and family too and neighbors and friends that it's become personal," Helena said, adding she first heard about the walk from client Marlene Rice of Eagle River, who will be participating in the event too.... | |
| |
| |
|
|
